Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Sivick, Kelsey E., Desbien, Anthony L., Glickman, Laura Hix, Reiner, Gabrielle L., Corrales, Leticia, Surh, Natalie H., Hudson, Thomas E., Vu, Uyen T. +17 more·2018·Cell Reports

DOI 10.1016/j.celrep.2018.11.047

Cited by (457)

Items 101–200 of 457

Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
Huan Zheng, Beibei Guo, Xinyun Qiu, Yifeng Xia, Yan Qu, Liang Cheng, Fenghua Meng, Zhiyuan Zhong · 2022 · Bioactive Materials
Targeting STING for cancer immunotherapy: From mechanisms to translation
Ruilei Huang, Qian Ning, Jihui Zhao, Xuhong Zhao, Luting Zeng, Yi Yi, Shengsong Tang · 2022 · International Immunopharmacology
Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy
Lixu Xie, Changwen Zhang, Miao Liu, Jianling Huang, Xiao Jin, Changjun Zhu, Minjie Lv, Ning Yang, Sixi Chen, Mingyue Shao et al. · 2023 · ACS Applied Materials & Interfaces
cGAS/STING signalling pathway in senescence and oncogenesis
Le Yu, Pengda Liu · 2024 · Seminars in Cancer Biology
Promising targets based on pattern recognition receptors for cancer immunotherapy
Ling Bai, Wenqian Li, Weijia Zheng, Dongsheng Xu, Naifei Chen, Jiuwei Cui · 2020 · Pharmacological Research
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
Kari A. Shaver, Tayler J. Croom-Perez, Alicja Joanna Copik · 2021 · Frontiers in Immunology
STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
Vonderhaar, Emily P., Barnekow, Nicholas S., McAllister, Donna, McOlash, Laura, Eid, Mahmoud Abu, Riese, Matthew J., Tarakanova, Vera L., Johnson, Bryon D., Dwinell, Michael B. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, Yongjian Cao, Zhihai Qin, Zhiyuan Zhong, Weijing Yang · 2023 · Advanced Healthcare Materials
STING Signaling and Sterile Inflammation
Isabelle Couillin, Nicolas Riteau · 2021 · Frontiers in Immunology
STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
Danilo Guerini · 2022 · Cells
Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion
Bin Wang, Maoping Tang, Qijing Chen, William Ho, Yilong Teng, Xiaojian Xiong, Zhitong Jia, Xiuling Li, Xiaoyang Xu, Xue‐Qing Zhang · 2024 · ACS Nano
A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant
Jun Wu, Lang Zhao, Bei-Bei Han, Hong‐Guo Hu, Bo-Dou Zhang, Wen-Hao Li, Yong‐Xiang Chen, Yanmei Li · 2020 · Chemical Communications
Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy
Dinh Chuong Nguyen, Kefan Song, Simbarashe Jokonya, Omeed Yazdani, Drew L. Sellers, Yonghui Wang, ABM Zakaria, Suzie Hwang Pun, Patrick S. Stayton · 2024 · ACS Central Science
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
C. Elizabeth Boudreau, Hinda Najem, Martina Ott, Craig Horbinski, Dexing Fang, Chase M. DeRay, Jonathan M. Levine, Michael A. Curran, Amy B. Heimberger · 2021 · Clinical Cancer Research
Mn 2+ /CpG Oligodeoxynucleotides Codecorated Black Phosphorus Nanosheet Platform for Enhanced Antitumor Potency in Multimodal Therapy
Kai Ling, Jintao Zheng, Xiaohong Jiang, Weijie Huang, Youqing Mai, Chuanghong Liao, Shuting Fan, Jianlan Bu, Rui Li, Bingchun Zeng et al. · 2024 · ACS Nano
XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A. Bukhalid, Jeremy R. Duvall, Kelly L. Lancaster, Kalli C. Catcott, Naniye Malli Cetinbas, Travis E. Monnell, Caitlin Ann Routhier, Joshua D. Thomas, Keith W. Bentley, Scott D. Collins et al. · 2025 · Clinical Cancer Research
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors
Jason J. Luke, David James Pinato, Dejan Juric, Patricia Mucci LoRusso, Peter J. Hosein, Anupam M. Desai, Robert I. Haddad, María de Miguel, Andrès M.R. Cervantes, Won Seog Kim et al. · 2025 · Journal for ImmunoTherapy of Cancer
Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines
Wenhao Li, Jingyun Su, Yanmei Li · 2022 · Accounts of Chemical Research
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
Constantia Pantelidou, Heta Jadhav, Aditi Kothari, Renyan Liu, Gerburg M. Wulf, Jennifer L. Guerriero, Geoffrey Ira Shapiro · 2022 · npj Breast Cancer
Delivery of STING agonists for cancer immunotherapy
Jianping Wang, Fanfei Meng, Yoon Yeo · 2024 · Current Opinion in Biotechnology
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route
Štěpán Vyskočil, David Cardin, Jeffrey P. Ciavarri, Joe Conlon, Courtney A. Cullis, Dylan B. England, Rachel E. Gershman, Kenneth M. Gigstad, Krista Gipson, Alexandra E. Gould et al. · 2021 · Journal of Medicinal Chemistry
Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo
Ji Young Yoo, Jessica L. Swanner, Yoshihiro Otani, Mitra Nair, Flora Park, Yeshavanth Banasavadi‐Siddegowda, Joseph N. Liu, Alena Cristina Jaime‐Ramirez, Bangxing Hong, Feng Geng et al. · 2019 · Neuro-Oncology
Why is Listeria monocytogenes such a potent inducer of CD8+ T‐cells?
Alfredo Chávez‐Arroyo, Daniel A. Portnoy · 2020 · Cellular Microbiology
Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer
Salomé Araujo‐Abad, José Marcos Berna, Elena Lloret-Lopez, Andrés López‐Cortés, Miguel Saceda, Camino de Juan Romero · 2024 · Cellular Oncology
SKIL facilitates tumorigenesis and immune escape of NSCLC via upregulating TAZ/autophagy axis
Fang Ma, Meng-Ge Ding, Yiyu Lei, Lihua Luo, Shun Jiang, Yuhua Feng, Xianling Liu · 2020 · Cell Death and Disease
Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents
Xi Feng, Lixia Pan, Zhiyu Qian, Dongyu Liu, Xin‐Yuan Guan, Feng Li, Bin Song, Xi Jin Xu, Ning‐Hua Tan, Yi Ma et al. · 2022 · Journal of Medicinal Chemistry
Cancer immunotherapy strategies that target the cGAS-STING pathway
Zhuoying Tian, Yue Zeng, Yurong Peng, Junqi Liu, Fang Wu · 2022 · Frontiers in Immunology
Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment
Faezzah Baharom, Dalton Hermans, Lélia Delamarre, Robert A. Seder · 2024 · Nature reviews. Immunology
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-Cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
Ali Hussainy Zaidi, Ronan Joseph Kelly, Anastasia Gorbunova, Ashten N. Omstead, Madison S. Salvitti, Ping Zheng, Juliann E. Kosovec, Soyoung Lee, Shahin Ayazi, Laila Babar et al. · 2021 · Oncotarget
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I + tumors
Natalie K. Wolf, Cristina Blaj, Lora K. Picton, Gail Snyder, Li Zhang, Christopher J. Nicolai, Chudi O. Ndubaku, Sarah M. McWhirter, K. Christopher García, David H. Raulet · 2022 · Proceedings of the National Academy of Sciences
Computational study on new natural compound agonists of stimulator of interferon genes (STING)
Sheng Zhong, Weihang Li, Yang Bai, Bo Wu, Xinhui Wang, Shanshan Jiang, Yingjing Zhao, Jiaxin Ren, Hui Li, Rihua Jin · 2019 · PLoS ONE
The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases
Ruoyu Zhou, Xiaoli Xie, Xinbo Li, Ziyi Qin, Chuanyu Wei, Jing Liu, Ying Luo · 2019 · Infection Genetics and Evolution
Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response
Fan Shi, Jin Su, Juan Wang, Zi Liu, Tao Wang · 2020 · Molecular and Cellular Biochemistry
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
Maite Álvarez, Carmen Molina, Carlos E. de Andrea, Myriam Fernández-Sendin, María Villalba-Esparza, José González-Gomariz, María Carmen Ochoa, Álvaro Teijeira, Javier Glez‐Vaz, Fernando Aranda et al. · 2021 · Journal for ImmunoTherapy of Cancer
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy
Weiyue Zhang, Xin Huang · 2025 · Biomarker Research
Inflammatory signaling in genomically instable cancers
Francien Talens, Marcel A.T.M. van Vugt · 2019 · Cell Cycle
Improving STING Agonist Delivery for Cancer Immunotherapy Using Biodegradable Mesoporous Silica Nanoparticles
Kyung Soo Park, Cheng Xu, Xiaoqi Sun, Cameron Louttit, James Jaehyun Moon · 2020 · Advanced Therapeutics
Macrophages: Targets for next-generation cancer immunotherapy
Xiaoqi Sun, Matthew D. Park, Miriam Mérad, Brian D. Brown · 2026 · Cancer Cell
Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour
Seung‐hwan Jeong, Myung Jin Yang, Seunghyeok Choi, JungMo Kim, Gou Young Koh · 2021 · Nature Communications
DNA damage repair kinase DNA‐PK and cGAS synergize to induce cancer‐related inflammation in glioblastoma
Clara Taffoni, Johanna Marines, Hanane Chamma, Soumyabrata Guha, Mathilde Saccas, Amel Bouzid, Ana Luiza Chaves Valadão, Clément Maghe, Jane Jardine, Mi Kyung Park et al. · 2022 · The EMBO Journal
Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling
Matilde Monti, Giorgia Ferrari, Luisa Gazzurelli, Mattia Bugatti, Fabio Facchetti, William Vermi · 2024 · Journal of Experimental & Clinical Cancer Research
An mRNA vaccine elicits STING-dependent antitumor immune responses
Zhe Chen, Chaoyang Meng, Junhua Mai, Yongbin Liu, Hangwen Li, Haifa Shen · 2022 · Acta Pharmaceutica Sinica B
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases
Jin Kyung Seok, Minhyuk Kim, Han Chang Kang, Yong‐Yeon Cho, Hye Suk Lee, Joo Young Lee · 2023 · Archives of Pharmacal Research
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
Shyambabu Chaurasiya, Annie Yang, Seonah Kang, Jianming Lü, Sang‐In Kim, Anthony K. Park, Venkatesh Sivanandam, Zhifang Zhang, Yanghee Woo, Susanne Gray Warner et al. · 2020 · OncoImmunology
Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment
Théo Accogli, Mélanie Bruchard, Frédérique Végran · 2021 · Cancers
Moonlighting Proteins Are Important Players in Cancer Immunology
Annalisa Adamo, Cristina Frusteri, Maria Teresa Pallotta, Tracey Pirali, Silvia Sartoris, Stefano Ugel · 2021 · Frontiers in Immunology
If small molecules immunotherapy comes, can the prime be far behind?
Jingyu Zhang, Yu Zhang, Bingxue Qu, Haiyan Yang, Shengquan Hu, Xiaowu Dong · 2021 · European Journal of Medicinal Chemistry
CD4 T cell–activating neoantigens enhance personalized cancer vaccine efficacy
Amanda L. Huff, Gabriella Longway, Jacob T. Mitchell, Lalitya Andaloori, Emily F. Davis-Marcisak, Fangluo Chen, Melissa R. Lyman, Rulin Wang, Jocelyn Mathew, Benjamin Barrett et al. · 2023 · JCI Insight
Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions
Nicholas W. Colangelo, Naamit Kurshan Gerber, Ralph E. Vatner, Benjamin Thomas Cooper · 2024 · Frontiers in Pharmacology
The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to Humans
Karim Majzoub, Florian Wrensch, Thomas F. Baumert · 2019 · Viruses
A Mn 2+ ‐Assisted Nanofiber‐Hydrogel Adjuvant for Simultaneous Enhancement of Humoral and Cellular Immune Responses
Haixue Jia, Lin Jia, Dianyu Wang, Xue Lv, Qian Wang, Zhongyan Wang, Jinjian Liu, Lijun Yang, Jianfeng Liu · 2024 · Advanced Functional Materials
Epigenetically suppressed tumor cell intrinsic STING promotes tumor immune escape
Hui Zheng, Lizhen Wu, Qian Xiao, Xin Meng, Alex Hafiz, Qin Yan, Renquan Lu, Jian Ping Cao · 2022 · Biomedicine & Pharmacotherapy
T‐cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy
Aida S. Hansen, Lea S. Jensen, Kristine Raaby Gammelgaard, Kristoffer G. Ryttersgaard, Christian Krapp, Jesper Just, Kasper L. Jønsson, Pia Bomholt Jensen, Thomas P. Boesen, Mogens Johannsen et al. · 2023 · Journal of Extracellular Vesicles
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
Jiawen Zhang, Sihui Yu, Qiao Peng, Ping Wang, Lan Fang · 2024 · Cancer Biology and Medicine
cGAS-STING pathway expression as a prognostic tool in NSCLC
Kristine Raaby Gammelgaard, Birgitte Sandfeld‐Paulsen, Stine Høvring Godsk, Christina Demuth, Peter Meldgaard, Boe Sandahl Sørensen, Martin R. Jakobsen · 2021 · Translational Lung Cancer Research
Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4+ T cells through regulating type 2 conventional dendritic cells
Jing Luo, S.S. Pang, Zhenzhen Hui, Hua Zhao, Shilei Xu, Wenwen Yu, Lili Yang, Qian Sun, Xishan Hao, Feng Wei et al. · 2023 · Theranostics
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
Ahmad Kamel Mostafa Abo Zaid, Amiram Ariel · 2024 · Advanced Drug Delivery Reviews
A nanoplatform to boost multi-phases of cancer-immunity-cycle for enhancing immunotherapy
Cuixia Zheng, Qingling Song, Hongjuan Zhao, Yueyue Kong, Lingling Sun, Xinxin Liu, Qianhua Feng, Lei Wang · 2021 · Journal of Controlled Release
STING trafficking activates MAPK–CREB signaling to trigger regulatory T cell differentiation
Wei Lin, C. Z. K. Szabo, Tao Liu, Huangheng Tao, Xianfang Wu, Jianjun Wu · 2024 · Proceedings of the National Academy of Sciences
Breaking barriers: The cGAS‐STING pathway as a novel frontier in cancer immunotherapy
Yuheng Yan, Ximin Tan, Bin Song, Ming Yi, Qian Chu, Kongming Wu · 2025 · 癌症：英文版
Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells
Kyong Soo Park, Jutaek Nam, Sejin Son, James Jaehyun Moon · 2021 · Biomaterials
Targeting STING to generate therapeutic anti-tumor immunity
Caroline G. Fahey, Anthony F. Cordova, Patrick C. Gedeon, David Allen Barbie · 2025 · Cancer Cell
STING couples with PI3K to regulate actin reorganization during BCR activation
Yukai Jing, Xin Dai, Lu Yang, Danqing Kang, Panpan Jiang, Na Li, Jiali Cheng, Jingwen Li, Heather E. Miller, Boxu Ren et al. · 2020 · Science Advances
TREX1 cytosolic DNA degradation correlates with autoimmune disease and cancer immunity
Liwei Fang, Songcheng Ying, Xi Xu, De Wu · 2023 · Clinical & Experimental Immunology
Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, Qikai Peng, Xingdong Wang, Xiyue Xiao, Kai Shi · 2024 · Acta Biomaterialia
The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy
Ana Rita Salgado Ribeiro, Theresa Neuper, Jutta Horejs‐Hoeck · 2024 · International Journal of Nanomedicine
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
Jason J. Luke, Randy F. Sweis, Joel Randolph Hecht, Reva Schneider, Mark N. Stein, Talia Golan, Timothy Anthony Yap, Anuradha D. Khilnani, Mo Chao Huang, Runchen Zhao et al. · 2025 · Clinical Cancer Research
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors
Tina Chang Albershardt, Jardin A. Leleux, Andrea Jean Parsons, Jordan Edward Krull, Peter Berglund, Jan ter Meulen · 2020 · npj Vaccines
Type I interferons in pancreatic cancer and development of new therapeutic approaches
Amber Blaauboer, Kostandinos Sideras, Casper H.J. van Eijck, Leo J. Hofland · 2020 · Critical Reviews in Oncology/Hematology
Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
Samuele Stazzoni, Daniel F. R. Böhmer, Fabian Hernichel, Dilara Özdemir, Aikaterini Pappa, David Drexler, Stefan Bauernfried, Gregor Witte, Mirko Wagner, Simon Veth et al. · 2022 · Angewandte Chemie International Edition
Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma
Y. Zhang, Q. Zhai, Xiaowen Feng, Dong Chen, Yuexin Lu, Jiahao Hu, Haiyang Xie, Liqun Zhou, Jian Wu, Sui Zheng · 2021 · Clinical & Translational Oncology
Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
Kuan‐Chun Huang, Dinesh Chandra, Shannon M. McGrath, Vaishali S. Dixit, Chi Zhang, Jiayi Wu, Karen TenDyke, Huilan Yao, Renee Rosemary Hukkanen, Noël Taylor et al. · 2022 · Molecular Cancer Therapeutics
Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines
Geoffrey M. Lynn, Richard Laga, Christopher M. Jewell · 2019 · Cancer Letters
The pleiotropic roles of cGAS–STING signaling in the tumor microenvironment
Jun Li, Samuel F. W. Bakhoum · 2022 · Journal of Molecular Cell Biology
Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy
Jun‐Long Liang, Xiao‐Kang Jin, Xin‐Chen Deng, Qian‐Xiao Huang, Shi‐Man Zhang, Wei‐Hai Chen, Xian‐Zheng Zhang · 2024 · Materials Today
Targeting DNA damage response pathways to activate the STING innate immune signaling pathway in human cancer cells
Joanne Wayne, Teresa Brooks, Alexandra Landras, Andrew J. Massey · 2021 · FEBS Journal
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation
Lauren E. Milling, Daniel Garafola, Yash Agarwal, Shengwei Wu, Ayush Thomas, Nathan D. Donahue, Josetta Adams, Nikki Thai, Heikyung Suh, Darrell J. Irvine · 2021 · Cancer Immunology Research
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
Bin Shan, Hui Hou, Keke Zhang, Rui Li, Chang Shen, Zhengyang Chen, Peijia Xu, Rongrong Cui, Zhaoming Su, Changfa Zhang et al. · 2023 · Journal of Medicinal Chemistry
Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma
Sare Hajiabadi, Soodeh Alidadi, Zohreh Montakhab Farahi, Mohammad Mahdi Ghahramani Seno, Hamidreza Farzin, Alireza Haghparast · 2023 · Frontiers in Immunology
A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window
Jian Wang, Xiaohu Wang, Qingqing Xiong, Shan Gao, Shihao Wang, Siqi Zhu, Shuting Xiang, Mingxi Li, Haitang Xie, Suxin Li · 2024 · Cell Reports Medicine
Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity
Huanling Zhang, Zining Wang, Jiaxin Wu, Yongqiang Zheng, Qi Zhao, Shuai He, Hang Jiang, Chang Jiang, Tiantian Wang, Yongxiang Liu et al. · 2025 · Journal of Clinical Investigation
Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
Ruben Serrano, Marcus Lettau, Michał Konrad Zarobkiewicz, Daniela Wesch, Christian Peters, Dieter Kabelitz · 2022 · OncoImmunology
Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor
Min Jae Jeon, Hyelim Lee, Jeehee Lee, Soo Yeon Baek, Dong-Hee Lee, Seongman Jo, Joo‐Youn Lee, Miso Kang, Hee Ra Jung, Soo Bong Han et al. · 2022 · Journal of Medicinal Chemistry
Mitochondria-Derived Damage-Associated Molecular Patterns in Sepsis: From Bench to Bedside
Sicheng Li, Qiongyuan Hu, Jinjian Huang, Xiuwen Wu, Jianan Ren · 2019 · Oxidative Medicine and Cellular Longevity
STING controls T cell memory fitness during infection through T cell-intrinsic and IDO-dependent mechanisms
Michael J. Quaney, Curtis John Pritzl, Dezzarae Luera, Rebecca J. Newth, Karin M. Knudson, Vikas Saxena, Caitlyn Guldenpfennig, Diana Gil, Chris S. Rae, Peter Lauer et al. · 2023 · Proceedings of the National Academy of Sciences
Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy
Jia Tan, Meifang Wang, Binbin Ding, Ping’an Ma, Jun Lin · 2023 · Coordination Chemistry Reviews
Novel formulation of c-di-GMP with cytidinyl/cationic lipid reverses T cell exhaustion and activates stronger anti-tumor immunity
Xiaotong Yu, Jing Yu, Hong Dai, Chenyun Deng, Xudong Sun, Sijie Long, Zhujun Jiang, Hongyan Jin, Zhu Guan, Zhenjun Yang · 2022 · Theranostics
cGAS-STING at the crossroads in cancer therapy
Rui Wang, Aashiq Hussain, Quanquan Guo, Meimei Ma · 2023 · Critical Reviews in Oncology/Hematology
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment
Tatyana V. Korneenko, Nikolay Borisovich Pestov, Ivan A. Nevzorov, Alexandra A. Daks, Трачук Кирилл Николаевич, О. Н. Солопова, Nickolai A. Barlev · 2023 · Pharmaceuticals
Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy
Haixia Wang, Zheng Liu, Youqiang Fang, Xing Luo, Chunxiong Zheng, Yanteng Xu, Xiangfu Zhou, Qing Yuan, Shixian Lv, Limin Ma et al. · 2024 · Biomaterials
Progress Update on STING Agonists as Vaccine Adjuvants
Yanru Shen, Weijin Huang, Jianhui Nie, Li Zhang · 2025 · Vaccines
Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus
Alireza Hashemzadeh, Amir Avan, Gordon A. Ferns, Majid Khazaei · 2020 · Vaccine
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
Olivia K. Burn, Kef Prasit, Ian F. Hermans · 2020 · Cancers
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, Jonathan R. Xu, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Jianxin You · 2022 · International Journal of Molecular Sciences
DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS–STING signalling
Otto P.G. Wheeler, Leonie Unterholzner · 2023 · Essays in Biochemistry
Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation
Li Liu, Shengxiang Fu, Haojie Gu, Yangqian Li, Guonian Zhu, Hua Ai, Weimin Li · 2025 · ACS Nano
STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway
Mingming Yin, Jinlong Hu, Zhongxu Yuan, Guangyi Luo, Jiaming Yao, Rundong Wang, Dongquan Liu, Baoqiang Cao, Wenyong Wu, Zhiqi Hu · 2022 · Cell Cycle
The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges
Zheqi Zhou, Sanling Huang, Fangying Fan, Yan Xu, Casey Moore, Sirui Li, Chuanhui Han · 2024 · Medical Review
Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act
Xujun Cao, Anthony F. Cordova, Lingyin Li · 2021 · Chemical Reviews
Intratumoral therapies and in-situ vaccination for melanoma
Laura Ann Huppert, ADIL I. DAUD · 2022 · Human Vaccines & Immunotherapeutics